2/26/2013 6:19:37 AM
SILVER SPRING, Md., Feb. 26, 2013 /PRNewswire/ -- United Therapeutics Corporation today announced its financial results for the fourth quarter and year ended December 31, 2012.
"Our excellent annual results reflect both our leadership in pulmonary hypertension medicines and our discipline in focusing company resources on transformative growth opportunities," noted Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "It is especially noteworthy that our medicines are now being prescribed to more pulmonary hypertension patients in the United States than any other company's medicines."
comments powered by